Page last updated: 2024-12-08

1,2-diphytanoylphosphatidylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

## 1,2-diphytanoylphosphatidylcholine: A Unique Phospholipid

**1,2-diphytanoylphosphatidylcholine** (DPPC) is a phospholipid with a very specific structure that sets it apart from other common phospholipids. It consists of:

* **Glycerol:** A three-carbon molecule that forms the backbone of the phospholipid.
* **Two phytanoyl chains:** These are long, branched fatty acid chains attached to the glycerol molecule. Phytanoyl chains are derived from the phytol side chain of chlorophyll and are unique for their branched structure, making them very resistant to degradation.
* **Phosphorylcholine headgroup:** This polar headgroup is attached to the glycerol molecule and makes DPPC a zwitterionic molecule (carrying both positive and negative charges).

**Why is DPPC important for research?**

DPPC's unique properties make it a valuable tool in various research fields:

**1. Membrane Model Systems:**

* **Liposomes:** DPPC is commonly used to form liposomes, which are artificial membrane vesicles. These liposomes can be used to study membrane properties, drug delivery, and other biological processes.
* **Monolayers:** DPPC can also be used to form monolayers at air-water interfaces, providing a model system to study the behavior of lipids at interfaces.
* **Langmuir-Blodgett Films:** DPPC can be used to create thin, ordered films on solid surfaces, mimicking cell membranes for research on membrane properties.

**2. Membrane Structure and Dynamics:**

* **Phase Transitions:** DPPC undergoes a distinct phase transition from a gel phase to a liquid-crystalline phase at around 41°C. This transition is crucial for understanding the behavior of cell membranes under different temperature conditions.
* **Lipid Raft Formation:** DPPC is a major component of lipid rafts, which are microdomains in cell membranes with specific lipid compositions and functions. Studying DPPC can provide insights into the formation and function of these rafts.

**3. Drug Delivery and Bioavailability:**

* **Drug Encapsulation:** The unique structure of DPPC can be exploited to encapsulate drugs within liposomes. This allows for controlled drug release and increased bioavailability.
* **Targeting and Delivery:** DPPC can be modified with specific targeting moieties, allowing for drug delivery to specific cells or tissues.

**4. Biophysical Studies:**

* **X-ray Diffraction:** DPPC's well-defined structure makes it suitable for X-ray diffraction studies, which can provide detailed information about the arrangement of lipids in membranes.
* **NMR Spectroscopy:** DPPC is also a good model system for nuclear magnetic resonance (NMR) spectroscopy, allowing researchers to study the dynamics and interactions of lipids in membranes.

**In conclusion, 1,2-diphytanoylphosphatidylcholine is a valuable tool for researchers across a wide range of disciplines, particularly in membrane biology, drug delivery, and biophysical studies.** Its unique structure and properties make it a powerful model system for investigating the intricate workings of cell membranes and exploring novel applications in medicine and other fields.

Cross-References

ID SourceID
PubMed CID169428
MeSH IDM0075432

Synonyms (13)

Synonym
1,2-diphytanoylphosphatidylcholine
2,3-bis[(3,7,11,15-tetramethylhexadecanoyl)oxy]propyl 2-(trimethylammonio)ethyl phosphate
32448-32-1
1,2-diphytanoyl-sn-glycero-3-phosphocholine
dphypc
3,5,9-trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-n,n,n,12,16,20,24-heptamethyl-10-oxo-7-((3,7,11,15-tetramethyl-1-oxohexadecyl)oxy)-, hydroxide, inner salt, 4-oxide
diphytanoyl lecithin
64626-70-6
DTXSID30276594
DTXSID80954198
2,3-bis[(3,7,11,15-tetramethylhexadecanoyl)oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate
PD088569
2,3-bis((3,7,11,15-tetramethylhexadecanoyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (141)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (10.64)18.7374
1990's23 (16.31)18.2507
2000's41 (29.08)29.6817
2010's56 (39.72)24.3611
2020's6 (4.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other144 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]